News
18hon MSN
Researchers at the German Center for Cardiovascular Research (DZHK) have identified a key molecule involved in a form of ...
The new Tempus software analyzes resting, non-ambulatory 12-lead ECG recordings to detect signs associated with having a low ...
Zacks Investment Research on MSN15h
TEM Shares Surge on New AI Breakthrough: Should Investors Jump In?Tempus AI TEM jumped 7.3% at yesterday’s close after securing FDA 510(k) clearance for its ECG-Low EF software, its second greenlighted AI tool in cardiology. The approval adds fuel to a stock already ...
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue from sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback